Subject(s)
Humans , Male , Child , Folliculitis/diagnosis , Folliculitis/drug therapy , Masks/adverse effects , Lymphoproliferative DisordersSubject(s)
Folliculitis , Lymphoproliferative Disorders , Humans , Folliculitis/diagnosis , Folliculitis/etiologyABSTRACT
Oral minoxidil is an approved treatment for high blood pressure which is also used as an off-label drug for alopecia. Knowledge about the effects of systemic minoxidil in the paediatric population is limited. A retrospective case series study of paediatric patients with history of systemic minoxidil intake due to contaminated sets of omeprazole was performed to describe side effects of high dose oral minoxidil intake in children. Twenty patients aged between 2 months and 13 years joined the study. They had received high doses of oral minoxidil (mean dose 0.90 mg/kg/day) during a mean time of 38.3 days. Hypertrichosis appeared in 65%, with a mean latency time of 24.31 days. Treatment time was associated with the appearance of hypertrichosis (p < 0.05). Most common initial zone of hypertrichosis was the face. Systemic effects developed in 15%, with no cases of severe disorders. The present study shows a novel insight into the side effects of high doses of oral minoxidil in children.
Subject(s)
Calcinosis , Skin Diseases , Skin Neoplasms , Humans , Skin Diseases/diagnosis , Skin Diseases/drug therapy , Skin Diseases/etiologyABSTRACT
The presence of eczema and elevated IgE in pediatric patients does not always indicate atopic dermatitis. Rare genodermatoses may share this clinical presentation and should be considered in the differential diagnosis for patients with congenital immunodeficiency and severe refractory dermatitis. We describe a case of severe dermatitis, allergies, and metabolic wasting syndrome, due to a novel mutation in DSG1 gene, an additional example of this uncommon genetic disorder of desmosome function.
Subject(s)
Dermatitis, Exfoliative , Eczema , Hypersensitivity , Wasting Syndrome , Child , Dermatitis, Exfoliative/diagnosis , Dermatitis, Exfoliative/genetics , Desmoglein 1 , Eczema/diagnosis , Humans , Wasting Syndrome/diagnosisABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Morgellons Disease/drug therapy , Quetiapine Fumarate/administration & dosage , Paranoid Disorders/complications , Paranoid Disorders/drug therapy , Risperidone/therapeutic use , Mupirocin/therapeutic use , Bandages, HydrocolloidABSTRACT
No disponible
Subject(s)
Humans , Female , Adolescent , Mycosis Fungoides/diagnosis , Mycosis Fungoides/drug therapy , Erythromycin/administration & dosage , Porokeratosis/drug therapy , Diagnosis, Differential , Warts/complications , Tinea/complications , Porokeratosis/complicationsABSTRACT
We report a 50-year-old male patient who presented to the Dermatological Outpatient Clinic at the Hospital Universitario San Cecilio, Granada, Spain, in 2017 with symmetrical inguinal eruption and eruption on the dorsum of both feet four hours after the intake of amoxicillin. Physical examination showed confluent non-palpable purpuric macules covering the dorsum of both feet and medial malleolus, giving rise to dusky erythema in some areas. Only oral antihistamines were prescribed and cutaneous exanthema resolved within three weeks. Symmetric drug-related intertriginous and flexural exanthema (SDRIFE) is a sub-type of systemic allergic contact dermatitis, where previous sensitisation can only be demonstrated in up to 50% of patients by skin patch testing. Therefore, a provocation test was performed with amoxicillin without prior skin patch testing. As drug provocation produced the same reaction, the patient was diagnosed with SDRIFE. A parvovirus B19 infection was ruled out by negative serology. SDRIFE is challenging to distinguish from other skin rashes with similar features and distribution; it is important to be aware of these characteristics and their possible causes.
Subject(s)
Amoxicillin/adverse effects , Anti-Bacterial Agents/adverse effects , Exanthema/chemically induced , Foot Dermatoses/chemically induced , Histamine Antagonists/therapeutic use , Amoxicillin/administration & dosage , Anti-Bacterial Agents/administration & dosage , Drug Eruptions , Exanthema/drug therapy , Exanthema/pathology , Foot Dermatoses/drug therapy , Foot Dermatoses/pathology , Humans , Male , Middle Aged , Treatment OutcomeSubject(s)
Antipsychotic Agents/therapeutic use , Morgellons Disease/drug therapy , Quetiapine Fumarate/therapeutic use , Adult , Humans , Male , Morgellons Disease/complications , Morgellons Disease/diagnosis , Morgellons Disease/psychology , Pruritus/etiology , Schizophrenia, Paranoid/complications , Schizophrenia, Paranoid/drug therapyABSTRACT
No disponible
